If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
638.00    -3.00 (-0.47%)
Bid:
638.00
Ask:
639.00
Spread: 1.00 (0.157%)
Market Cap: £708.02m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Directorate changes announcement

26 Mar 2024 07:00

RNS Number : 2331I
Barr(A.G.) PLC
26 March 2024
 

IMMEDIATE RELEASE 26 March 2024

 

A.G. BARR p.l.c.

("A.G. BARR" or the "Company")

 

A.G. BARR is a branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.

 

Directorate changes announcement

 

The Board of Directors (Board) of A.G. BARR p.l.c. announces that Jonathan Kemp has advised the Board that, owing to family health reasons, he will not seek re-election as a statutory director of the Company at its Annual General Meeting scheduled to take place on 31 May 2024 (AGM) and will retire as a director of the Company following conclusion of the AGM. In order to facilitate a smooth leadership transition, Jonathan will continue to lead the Commercial function until 30 September 2024. Thereafter he will remain available to the Company as required for a further twelve month period following which he will retire from the business. The business will commence a recruitment process in due course to identify a successor - this role will not be an executive director Board position.

 

As previously communicated on 26 May 2023, after nine years as a Non-Executive Director, David Ritchie will stand down from the Board with effect from the conclusion of the AGM. David will be succeeded by Louise Smalley as Remuneration Committee Chair.

 

Mark Allen, Chair of A.G. BARR, commented "On behalf of the Board, I would like to thank Jonathan for his significant contribution to A.G. BARR for over 20 years. As Commercial Director, he has been instrumental to the growth of the Company, with the business in a strong position to continue to grow and develop. We wish him and his family all the very best for the future. I would also like to thank David for his commitment and contribution to the business over many years. The Board has benefitted from his extensive knowledge and experience and wishes him well with his future endeavours."

 

For more information, please contact:

 

A.G. BARR 0330 390 3900

Mark Allen, Chair

Instinctif Partners  020 7457 2020

Justine Warren

Matthew Smallwood

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDXBXDDGSU
Date   Source Headline
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update
28th Mar 20237:00 amRNSFinal results for the year ended 29 January 2023
8th Mar 202310:57 amRNSDirector/PDMR Shareholding
8th Feb 202311:09 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
27th Jan 20232:39 pmRNSNotice of Trading Update
10th Jan 20232:01 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition of MOMA minority shareholding
14th Dec 20226:00 pmRNSContourGlobal
8th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition of Boost Drinks Holdings Limited
8th Nov 202210:41 amRNSDirector/PDMR Shareholding
1st Nov 20222:38 pmRNSDirector/PDMR Shareholding
1st Nov 20222:34 pmRNSDirector/PDMR Shareholding
1st Nov 20222:30 pmRNSDirector/PDMR Shareholding
25th Oct 20229:34 amRNSDirectorship
10th Oct 20221:44 pmRNSDirector/PDMR Shareholding
27th Sep 20227:05 amRNSUpdate statement on 2022 AGM Voting Results
27th Sep 20227:00 amRNSInterim Results
12th Sep 20223:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.